trial · primary record
VT-101
Epithelial Ovarian Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 22 |
| Primary completion | 2030-10-23 |
| Primary endpoint | Number of Participants With Dose-Limiting Toxicities (DLTs) |
| Registry ID | NCT07905677 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:11.251Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905677
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.